Peter Allen
Chairman at BENEVOLENTAI
Net worth: 416 202 $ as of 2024-05-30
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Timothy Cowper | M | - |
Celltech Group Plc
Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | 19 years |
Richard Bungay | M | 55 |
Celltech Group Plc
Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | 7 years |
Zillah Byng-Thorne | F | 48 | 11 years | |
Penelope Ladkin-Brand | F | 46 | 9 years | |
John Schoellerman | M | - | 5 years | |
Richard Huntingford | M | 68 | 7 years | |
Allan Mark Watson | M | 57 |
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | 15 years |
Elizabeth Shanahan | F | 59 | 2 years | |
Samuel Cameron Williams | M | 55 |
Istesso Ltd.
Istesso Ltd. BiotechnologyHealth Technology Istesso Ltd. Operates as a drug discovery and development company. The company was founded in 2017 and is headquartered in London, the United Kingdom. | 17 years |
Adrian Hennah | M | 66 | 3 years | |
Guy Asher Harmelin | M | 45 | 4 years | |
Richard Paling | M | - | 7 years | |
Hannah Coote | F | - | 4 years | |
Amanda Miller | F | - | 7 years | |
John Orloff | M | 66 | 3 years | |
Jean Raby | M | 60 | 2 years | |
Lisa Patel | M | - |
Istesso Ltd.
Istesso Ltd. BiotechnologyHealth Technology Istesso Ltd. Operates as a drug discovery and development company. The company was founded in 2017 and is headquartered in London, the United Kingdom. | - |
Nigel Shadbolt | M | 68 | 4 years | |
Douglas Le Fort | M | 58 | 3 years | |
William Scrimshaw | M | - | 5 years | |
Grahame Cook | M | 66 | 3 years | |
Wendy Becker | F | 58 | 3 years | |
Ivan Griffin | M | 48 | 11 years | |
John Geoffery Goddard | M | 73 | 9 years | |
Toshifumi Mikayama | M | 66 |
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | 12 years |
Sarah Lapworth | F | - | 11 years | |
Catherine Tucker | F | - | 5 years | |
Constantinos Neophytou | M | - | 4 years | |
Christina Busmalis | F | - | 1 years | |
Fleur Wood | F | - | - | |
Anna Fullerton Batten | F | - | 2 years | |
Sara Agee Le | M | - | 3 years | |
Richard Compton | M | - | 8 years | |
Philip Watkins | M | - | 4 years | |
Jordan J. Herman | M | - | 3 years | |
Anne Phelan | M | 59 | 5 years | |
Emma Alice Ide Stanton | F | 48 | 4 years | |
Stevo Knezevic | M | - |
Proximagen Group Plc
Proximagen Group Plc Miscellaneous Commercial ServicesCommercial Services Proximagen Group Plc engages in the business of discovery and development of therapeutic treatments. The company was founded by Jenner Peter on November 2003 and is headquartered in Cambridge, the United Kingdom. | 14 years |
John O'Higgins | M | 59 | 5 years | |
Gemma Vallance | F | - |
Istesso Ltd.
Istesso Ltd. BiotechnologyHealth Technology Istesso Ltd. Operates as a drug discovery and development company. The company was founded in 2017 and is headquartered in London, the United Kingdom. | - |
David Keith Peters | M | - |
Istesso Ltd.
Istesso Ltd. BiotechnologyHealth Technology Istesso Ltd. Operates as a drug discovery and development company. The company was founded in 2017 and is headquartered in London, the United Kingdom. | - |
Cathy Tomlinson | F | - | 7 years | |
Samuel Herbert | M | 42 | 4 years | |
Jessica Archer | F | - | 10 years | |
Ying Li | M | - | 8 years | |
Catherine Isted | F | - | 1 years | |
Alan Richardson | M | 53 | 6 years | |
Luke Edson | M | - | 6 years | |
Andy Donnelly | M | - | 2 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Richard Haley | M | - | - | |
Graham David Harding | M | 58 | 2 years | |
Ian Leslie Ardill | M | 57 |
Diurnal Ltd.
Diurnal Ltd. Pharmaceuticals: MajorHealth Technology Part of Neurocrine Biosciences, Inc., Diurnal Ltd. is a European, British UK-headquartered specialty pharmaceutical company founded in 2004. The company is based in Cardiff, UK. The company is dedicated to developing lifelong treatments for rare and chronic endocrine conditions. | 2 years |
Ian James Nicholson | M | 64 |
Celltech Group Plc
Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | 14 years |
Robin Andrew John Sibson | M | 65 | - | |
Elmar Schnee | M | 65 | 1 years | |
Mary Tavener | F | 62 | 19 years | |
Mark William Wood | M | 72 | 7 years | |
Peter George Lutz | M | 63 | 7 years | |
Peter Jenner | M | - |
Proximagen Group Plc
Proximagen Group Plc Miscellaneous Commercial ServicesCommercial Services Proximagen Group Plc engages in the business of discovery and development of therapeutic treatments. The company was founded by Jenner Peter on November 2003 and is headquartered in Cambridge, the United Kingdom. | 7 years |
Francois Nader | M | 67 | 2 years | |
John Bowman | M | 67 | 11 years | |
Susan Liautaud | M | - | 2 years | |
Penelope Freer | F | 63 | 12 years | |
Timothy Jason Sparey | M | - |
Proximagen Group Plc
Proximagen Group Plc Miscellaneous Commercial ServicesCommercial Services Proximagen Group Plc engages in the business of discovery and development of therapeutic treatments. The company was founded by Jenner Peter on November 2003 and is headquartered in Cambridge, the United Kingdom. | - |
Sharon Curran | F | 56 | 1 years | |
Nicholas Keher | M | 42 | 2 years | |
Michael Venus | M | - | - | |
Emma Harvey | F | - | - | |
Nial Ferguson | M | - | - | |
Simon Estcourt | M | - | - | |
Madhu Davies | M | - | - | |
Peter M. Steinmann | M | 61 | 7 years | |
Martin Abell | M | - | 4 years | |
Marcello Damiani | M | 54 | 1 years | |
Roland Baron | M | - |
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | - |
John Hartup | M | 73 | 9 years | |
Claire MacLellan | F | 46 | 6 years | |
Harry Thomas Stratford | M | 54 |
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | 12 years |
Hugo Drayton | M | 64 | 10 years | |
Sebastian Bishop | M | 48 | 7 years | |
Anne Philomena Hyland | F | 64 | 4 years | |
Manjit K. Wolstenholme | F | 59 | 6 years | |
Auvo Antero Juhani Kaikkonen | M | 64 |
Inion Oy
Inion Oy BiotechnologyHealth Technology Inion Oy is a medical devices company focused on the development and commercialization of innovative biodegradable and bioactive implants for applications in Spine and Specialty Orthopedics applications. By targeting key strategic markets in the USA and select territories in the rest of the world, Inion has built a product portfolio sold through a dedicated network of specialist distributors. Inion's products include biodegradable plates, screws, pins and membranes, which are used to enhance the healing of bone or soft tissue injuries, such as those caused by trauma or by reconstructive surgery. Inion's core expertise is in the design and manufacture of implants from its proprietary Inion Optima™ family of biomaterials, which enables the Company to develop medical implants with properties tailored for specific surgical applications, in terms of strength, flexibility and rate of degradation. Incorporated in 2000, Inion has offices in the UK and USA, and its head office, R&D and manufacturing facilities are in Tampere, Finland. | 9 years |
Olivier Brandicourt | M | 68 | 2 years | |
Mark Whiteling | M | 61 | 4 years | |
Donald W. Evans | M | 75 | 16 years | |
Stephen Bellamy | M | 64 | 14 years | |
Ian Johnson | M | 71 | 1 years | |
Stephanie Spring | F | 66 | 5 years | |
Adrian Gardner | M | 62 |
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | 5 years |
Nigel R. A. Beeley | M | 72 |
Celltech Group Plc
Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | 6 years |
Peter Edward Blackburn Cawdron | M | 81 |
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | - |
Simon Poulton | M | - | - | |
Paul M. Garvey | M | 71 |
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | 2 years |
Göran Albert Ando | M | 75 |
Celltech Group Plc
Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | 2 years |
Vicki Candler | F | - | 9 years | |
Michael J. Asbury | M | 80 |
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | - |
John Berriman | M | 76 |
Celltech Group Plc
Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | 7 years |
Statistics
Country | Connections | % of total |
---|---|---|
United Kingdom | 97 | 98.98% |
Finland | 1 | 1.02% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Peter Allen
- Personal Network